Recently, NMDA receptors (NMDARs) have been implicated in a cell contact-dependent suppression of sprouting in cultured Xenopus tectal neurons during an early period when neither AMPA/kainate (KA) receptors nor action potentials play a prominent role in cell-cell communication. We asked how the NMDA receptors function in the absence of the depolarizing effect of AMPA/KA receptor activity. We show that type II metabotropic glutamate receptors (mGluRs) can operate synergistically with NMDA receptors in the absence of AMPA/KA receptor function to suppress an early neurite sprouting response of the tectal neurons. Calcium imaging with fluo-3 AM and morphological analyses after exposure to glutamate receptor antagonists show that a combination of AMPA/KA receptor and type II mGluR blockers mimics the decrease in intracellular free calcium in response to glutamate and the structural effects produced by NMDA receptor antagonists in these cultures. Patch-clamp analyses confirmed a decrease in NMDA receptor-mediated currents with type II mGluR blockade, and 8-bromo cAMP application produced a decrease in NMDA receptor-mediated calcium influx. These data suggest that type II mGluRs potentiate NMDA receptor function by decreasing cAMP levels in tectal neurons. We also show that NMDARs exhibit low magnesium sensitivity in tectal neurons during the first few days in culture. Thus both metabotropic and ionotropic glutamate receptors can play a role in the contact-mediated suppression of ongoing sprouting at early neuron-neuron contacts before action potential activity.
Glutamate receptors are the most common excitatory neurotransmitter receptors in the brain. There are three major types of glutamate receptors, each believed to play a somewhat different role in development. AMPA/kainate receptors (AMPA/KARs) are required for rapid depolarization during glutamate-mediated transmission and pass the majority of ions during synaptic events in the mature brain (Hollmann and Heinemann, 1994) . NMDA receptors (NMDARs) are slower channels that require glutamate binding and depolarization (initiated by AMPA/KARs) to dislodge a Mg 2ϩ ion. This allows Ca 2ϩ to enter the cell and mediates the role of the NMDAR in synaptic plasticity (Burnashev, 1998) . Metabotropic glutamate receptors (mGluRs) are heterotrimeric G-protein-coupled receptors and are believed to modulate transmitter release (Cochilla and Alford, 1998) , calcium oscillations (Whittington et al., 1995) , and some usedependent changes in synaptic currents (Rahman and Neuman, 1996; Grover and Yan, 1999) .
Electrical activity modulates neuron growth and synapse formation primarily by regulating calcium levels in the cell (Mattson et al., 1988; Constantine-Paton and Cline, 1998) . Neuronal calcium levels have been implicated in neurite spine formation (Segal et al., 2000; Wu et al., 2001) , growth cone turning (Hong et al., 2000; Zheng, 2000; Gomez et al., 2001) , and gene transcription (Hardingham et al., 1999 (Hardingham et al., , 2001 . Inhibition of the NMDAR increases neurite outgrowth in several systems (Lin and Constantine-Paton, 1998; McKinney et al., 1999) , and spontaneous calcium oscillations have also been implicated in the early morphological differentiation of neurons Spitzer, 1995, 1997) and axon pathfinding (Gomez and Spitzer, 1999) .
In many of the preparations in which Ca 2ϩ effects on morphology have been studied, the initial events underlying synapse formation have already occurred. Using a Xenopus tectal neuron culture system, we showed previously that cell-cell contacts mediated NMDAR-dependent calcium changes, and NMDARs suppressed sprouting in early cultures before action potentials or glutamatergic synaptic currents are detected (Lin and Constantine-Paton, 1998) . The sprout suppression was contact dependent, because NMDAR blockade had no effect on sprouting of isolated cells in the same fields. Unexpectedly, blocking of AMPA/KARs did not alter sprouting in contacted cells, although combined AMPA/KAR and NMDAR blockade completely eliminated the calcium response to glutamate. This raised the question of how NMDAR-mediated Ca 2ϩ currents generated morphological change in young cells when AMPA/KAR blockade was without effect.
Here we show that combined AMPA/KAR and mGluR blockade eliminates the sprout suppression among contacted young neurons, mimicking the response observed with NMDAR antagonists alone. The effect is specific to type II mGluRs, which act by reducing cAMP levels. Type II mGluR blockade decreases NMDAR currents in the tectal cells, and application of the cAMP analog 8-bromo cAMP (8-Br cAMP) to tectal neurons reduces their NMDAR-mediated calcium influx. We also show that NMDARs on some very early neurons have a low sensitivity to magnesium, which disappears within 72 hr of culture. Our results suggest a role for mGluRs in regulating neurite formation and growth at very early stages of neuronal differentiation before synapse formation by modulating glutamate-mediated calcium influx through the NMDAR.
that the maximum fluorescence of most cells on the coverslip allowed at least a sixfold increase in fluorescence without saturating the image gray scale. C ells were then treated with 20 M glutamate or 100 M NMDA ϩ 5 M glycine for 60 sec, and a second set of 10 frames spaced 10 sec apart was acquired. The average fluo-3 AM intensity in these 10 frames was then taken as the response to that agonist (F ag ), and ⌬F ag was calculated as F ag Ϫ F o . The agonist was then washed out by perf usion with FSS for 10 min. This was followed by a 10 min perf usion of FSS containing one or more specific glutamate receptor antagonist(s) or 8-bromo-cAM P. Antagonist concentrations were identical to those used in the chronically treated cultures above, and 8-bromo-cAM P (RBI) was used at 5 or 10 M concentrations. Finally, as a control for bleaching during the experiment, either glutamate or NMDA was applied along with antagonist or 8-bromo-cAM P to each culture for 60 sec, and a third set of 10 frames spaced 10 sec apart was acquired. C ells with a final response that was Ͻ90% of the initial response were not used in this analysis. The response to agonist in the presence of antagonist was calculated as the average of these 10 frames (F agϩant ), and ⌬F agϩant was calculated as F agϩant Ϫ F o . The order of antagonist and agonist treatment was varied between coverslips to avoid introducing bias caused by order of presentation. mANOVA analysis was used to determine significant differences between antagonist ϩ agonist treatments. T ukey post hoc tests were used to compare differences between the antagonists, with results considered significant at the p ϭ 0.05 level.
Electrophysiolog y. Amphotericin-perforated patch-clamp recordings were made from cultured tectal neurons at 3 d in vitro (3 DIV). The cells were perf used with extracellular recording medium consisting of 115 mM NaC l, 2 mM KC l, 2.5 mM CaCl 2 , 1.5 mM MgC l 2 , 10 mM glucose, and 10 mM H EPES with pH adjusted to 7.3 using NaOH. Recording pipettes were filled with 110 mM K-gluconate, 10 mM KC l, 5 mM NaC l, 1.5 mM MgC l 2 , 0.5 mM EGTA, 20 mM H EPES, and 200 g /ml amphotericin B with pH adjusted to 7.3 by KOH. Amphotericin B was dissolved in DMSO and diluted to the final concentration just before use (Rae et al., 1991) . A Ͼ1.5 G⍀ seal was first obtained on an individual neuron soma, and the progress of tectal membrane perforation was then monitored as a change in access resistance from Ͼ1.5 G⍀ to ϳ25 M⍀. A second pipette was filled with 20 mM glutamate and placed 20 m away from the patched neurons. A 15 msec 20 psi pressure pulse was delivered to the pipette using a Picospritzer (General Valve). Antagonists were applied in the bathing medium and thoroughly washed out after each application. Currents were acquired using an Axopatch 200B amplifier (Axon Instruments) interfaced to a Digidata 1200 (Axon Instruments) and directly digitized with pC lamp 6.0 software for f urther off-line analysis.
Spontaneous calcium imag ing. Spontaneous calcium fluctuations were analyzed using the calcium-sensitive fluorophor fluo-3 AM. T wo protocols were applied. Under the first protocol, neurons were grown in normal Xenopus culture medium for 2 or 3 d and loaded with 5 M fluo-3 AM for 45-60 min in Xenopus culture medium. Pluronic acid F-127 (0.5 mg /ml) was added to facilitate dye loading. Coverslips containing the cultures were then placed in the imaging chamber and perf used for 10 -15 min at 2 ml /min with normal FSS (100 mM NaC l, 2 mM KC l, 2.5 mM CaCl 2 , 3 mM MgC l 2 , 5 mM glucose, and 5 mM H EPES) supplemented with appropriate antagonists before imaging. Images were collected on a Nikon PC M 2000 confocal microscope at one frame per 30 sec for 30 min using the 488 nm argon laser line and standard FI TC filter sets. The images were converted to TI FF files, and transferred to N IH Image for fluorescent intensity measurements using custom-written macros. To identif y calcium transients, the average fluorescence intensity of each cell was calculated by averaging all the measured values for that cell. The intensity of each cell at each time point was then normalized against that average value of the cell. Bleaching was minor and compensated for by multiplying the normalized brightness of each measured cell at each time point by the average normalized brightness of all cells at that time point and dividing this value by the average normalized brightness of all cells at all time points. A positive calcium signal was defined as any intensity measurement that exceeded 20% of the average normalized intensity for that individual cell. This criterion is similar to values used by other investigators (Flint et al., 1999) . Individual cells were compared across antagonist treatments by superimposing graphs of normalized calcium changes and comparing the duration and frequency of calcium transients.
A second protocol was used to determine whether spontaneous calcium fluctuations were altered by chronic glutamate receptor antagonist treatments. For this analysis, cultures were treated with glutamate antagonists for 3 d from plating and maintained in antagonist through all imaging procedures. Image collection, average baseline, and intensity measurements were the same as above. C alcium fluctuations were grouped into four categories using intensity and temporal characteristics identified by previous investigators (Gu et al., 1994; Flint et al., 1999) . Large calcium fluctuations were defined as events that had a maximum intensity at least 50% larger than the average intensity; events were considered small if their maximum intensity was Ͻ50% but Ͼ20% above average fluorescence. C alcium spikes were events that remained Ͼ20% above average for four or fewer consecutive frames (2 min or less). C alcium waves were defined as events that lasted for five or more frames (Ͼ2 min). Events were classified as large spikes, small spikes, large waves, or small waves. All events were scored for 60 -70 cells under each treatment condition, and the proportions of cells showing each type of calcium transient were compared across treatment groups. With these imaging conditions, our analyses may miss a fraction of the shortest duration calcium spikes yet include all calcium waves.
RESULTS

Glutamate receptors can act cooperatively to regulate neurite sprouting
We wished to determine how NMDARs in early cultures might be activated in the absence of action potentials driving glutamate release. Other classes of glutamate receptors offered likely candidates to modulate NMDAR function because they would respond to the same spontaneous vesicle fusion events that appear to stimulate early NMDARs. The number of neurite sprouts on contacted Xenopus neurons and isolated neurons in the same fields were tabulated separately at 3 DIV after chronic exposure to a range of glutamate receptor antagonists. Consistent with earlier results (Lin and Constantine-Paton, 1998 ) in all dissociations, the NMDAR antagonist AP-5 caused a significant increase in the number of neurite ends on contacted cells relative to isolated cells ( Fig. 1 A , Exp. 1, Exp. 2, Exp. 4 ) , whereas CNQX applied to sister cultures for the same duration was without effect (Fig. 1 A, Exp. 1 ). Also consistent with previous experiments in which the calcium chelator BAPTA induced contacted cell sprouting (Lin and Constantine-Paton, 1998) , the L-type calcium channel blocker nifedipine induced contacted neuron sprouting in these experiments ( Fig. 1 A, Exp. 3) . To test the hypothesis that mGluRs interact with NMDARs in the absence of AMPA/KAR activity to facilitate sprout suppression, tectal cultures were grown in combinations of the AMPA/KAR blocker CNQX and mGluR antagonists. When CNQX and the type I/type II mGluR antagonists E4CPG ( Fig. 1 A, Exp. 1) or MCPG ( Fig. 1 A, Exp. 2) were applied simultaneously, contacted cells showed numbers of neurite ends that were indistinguishable from uncontacted cells. This is identical to that seen with AP-5 treatment. Sister cultures treated separately with each mGluR antagonist or AMPA/KAR blockade showed normal sprout suppression ( Fig. 1 A , Exp. 1, Exp. 2) . Type III mGluR blockade, with or without CNQX, failed to alter sprout suppression ( Fig. 1 A, Exp. 3). Also dantrolene, applied alone or with the type I/type II mGluR antagonist E4CPG, failed to alter neurite sprouting among contacted cells ( Fig. 1 A, Exp. 3). These observations suggest that calcium release from intracellular stores is not critically involved in the response and that mGluR activity normally modulates the NMDAR in the downregulation of neurite sprouting when AMPA/KAR activity is low.
The neurite sprouting assay was subsequently repeated using specific antagonists for type I (AIDA) and type II (EGLU) mGluRs individually ( Fig. 1 A, Exp. 4 ). Neither of these specific mGluR antagonists alone eliminated the difference in neurite ends between contacted and isolated cells. In addition, the type I mGluR antagonist AIDA combined with CNQX had no significant effect on sprouting. In contrast, the type II mGluR antagonist EGLU coapplied with CNQX removed the contact-mediated sprout suppression ( Fig. 1 A , Exp. 4 ). This effect is illustrated in the photomicrographs of Figure 1 , B and C. Thus, in the absence of AMPA/KAR function, type II mGluRs interact with NMDARs to inhibit neurite sprouting in contacted tectal cells.
A number of investigations studying GABA A receptor (GABA A R) responses of neurons developing in situ have reported early depolarizing responses in response to GABA A R stimulation (Owens et al., 1996; Ben-Ari, 2001 ). Thus, we asked whether the 13% of tectal neurons in Xenopus tectal cultures that are GABAergic (Lin and Constantine-Paton, 1998 ) could produce the GABA A R-mediated depolarizations necessary to relieve the magnesium block on NMDARs. The GABA A R blocker bicuculline methiodide applied chronically from plating at 10 M consistently failed to eliminate the difference between the number of neurites on isolated or contacted tectal cells when assayed at 3 DIV (n ϭ 430 cells; 1.51 Ϯ 0.10 contacted neurites per cell; 2.87 Ϯ 0.32 isolated neurites per cell; Student's two-tailed t test, p ϭ 0.002). Because the GABA A R antagonist does not appear to increase sprouting in cultures of early tectal neurons, GABA probably does not play a significant role in depolarizing these cells.
Metabotropic glutamate receptors modulate glutamate-induced calcium currents
We used fluo-3 AM imaging of changes in intracellular free calcium (⌬F/F o ) to determine whether inhibition of glutamatetriggered calcium changes was involved in the synergistic effect of type II mGluR and AMPA/KAR antagonists on sprouting. We first determined ⌬F/F o of individual cultured neurons in response to glutamate alone; then we examined the reduction in that calcium response when specific glutamate receptor antagonists were coapplied. Figure 3 summarizes all of the data taken from neurons at 3 DIV for the effects on the calcium response to glutamate in the presence of all antagonists shown to influence the sprouting of contacted cells. As can be seen in the figure, AP-5 and CNQX depressed calcium influx, although to significantly different levels (ANOVA Tukey post hoc test; p ϭ 0.001). Nifedipine decreased calcium influx levels to that of CNQX, suggesting that the AMPA/KAR calcium response to glutamate may be mediated primarily by L-type calcium channels. Type I (AIDA), type II (EGLU), and type I/II (E4CPG) mGluR antagonists did not decrease calcium entry; in fact, consistent increases in the glutamate-induced calcium response of neurons were observed whenever type II mGluRs were blocked and ionotropic receptors were functioning. CNQX plus the type I antagonist AIDA also had no effect on the glutamate-induced calcium flux beyond that seen with AMPA/KAR blockade alone. However, antagonism of type II mGluRs (EGLU and E4CPG) when coapplied with CNQX suppressed calcium influx beyond that seen with CNQX alone (ANOVA Tukey post hoc test; p ϭ 0.0001) to levels indistinguishable from AP-5. These data suggest that type II mGluRs potentiate calcium influx when NMDARs are the only ionotropic glutamate receptors functioning on the tectal cell membranes.
Electrophysiological recordings from 3 DIV neurons confirmed a facilitating effect of mGluRs on NMDAR currents. At this age, spontaneous synaptic currents are not detectable. However, robust inward currents can be recorded with perforated-patch recording using a puff of glutamate (Fig. 4 A) . A representative series of traces using this technique is shown in Figure 4 B, and the electrophysiological results are summarized in Table 1 . Blockade of type II mGluRs using EGLU or type I/II mGluRs using E4CPG increased the peak glutamate induced current to an average of 146.7%, confirming the general increase seen using calcium imaging. Blockade of AMPA/KARs with CNQX resulted in an average reduction of the peak glutamate current to 72.3%. Metabotropic receptor blockers affecting type II mGluRs Each of the four experiments used cells from a single dissociation, and cells from two coverslips in the dissociation were analyzed for each antagonist treatment. A two-tailed Student's t test was performed between contacted and isolated cells on the same coverslip to compare the number of neurites per cell, and mANOVA analysis using a Tukey post hoc test compared differences between the number of neurites per contacted cell under different treatments within a given experiment. Statistics were not applied across experiments because of the dissociation-associated differences in overall sprouting. Multiple ANOVA analysis of free neurite ends among different treatments within a given experiment consistently revealed no changes in sprouting of isolated cells across the control and treatment groups. B, Differential interference contrast (DIC) images of dissociated tectal neurons in cultures treated with 20 M CNQX and 0.2 mM EGLU show significant sprouting from both isolated and contacted cells. Isolated cells are labeled with i, contacted cells are labeled with c, and free neurite ends are marked with a white dot. C, Control image showing more free neurite ends on isolated compared with contacted cells. Scale bar, 10 m.
(EGLU or E4CPG) coapplied with CNQX decreased the peak glutamate current to 39.7% and also consistently slowed its decay time (Fig. 4 B, lowest trace; Table 1 ). These results confirm the calcium imaging data and suggest that mGluRs can enhance NMDAR function in the absence of AMPA/KAR-mediated depolarization. However, when both ionotropic receptor subtypes are functioning on the cells, type II mGluR blockade actually enhances the glutamate current.
Earlier studies have suggested two ways in which mGluRs may alter NMDAR signaling. Metabotropic receptors could decrease the expression of NMDARs on the surface of the cell (Gomperts et al., 2000) or alter the permeability of the NMDAR channel when small depolarizations or low levels of magnesium allow marginal function (Cho et al., 2000) . To distinguish between these possibilities, cells were cultured for 3 d in EGLU ϩ CNQX, and the calcium responses of the neurons to NMDA and glycine in 3 mM magnesium or in magnesium-free FSS were measured using fluo-3. Acute NMDA exposure to both treated and control cells produced the same calcium response at 40 M and 100 M NMDA (data not shown). However, the magnitude of the calcium response to this saturating NMDAR stimulation was unchanged from the control after chronic exposure to EGLU ϩ CNQX (Fig.  5 ) regardless of whether magnesium was present in the medium. Thus, the cell surface NMDAR sensitivity of the neurons was not altered by the chronic glutamate receptor antagonist treatment. The magnesium sensitivity of NMDARs on 3 DIV tectal neurons was also unaffected by chronic AMPA/KAR and type II mGluR antagonism.
Spontaneous calcium oscillations do not correlate with an increase in neurite sprouting
As mentioned in the introductory remarks, neurons in culture and in vivo have been shown to have endogenously changing levels of calcium. Consequently, despite the robust acute effects of mGluRs on calcium responses to applied glutamate in tectal neurons, sprouting might be more directly linked to the effects of the antagonists on their spontaneous calcium transients. Using two different experimental paradigms, we tested for positive correlations between glutamate receptor antagonist effectiveness in increasing sprouting among contacted cells and in the effectiveness of the same antagonists in suppressing spontaneous calcium transients using two different experimental paradigms. First, we loaded cells with fluo-3 AM and recorded baseline spontaneous calcium changes every 30 sec for 30 min. The same cells were subsequently recorded during four additional 30 min sessions in the presence of CNQX, AP-5, MCPG, and CNQX ϩ MCPG. The calcium transients were subsequently examined across the various treatment conditions to look for a change from baseline that was consistently associated with exposure to AP-5 or to CNQX ϩ MCPG. None of these acute, short-term treatments consistently altered the frequency of spontaneous calcium transients in the tectal cells (Table 2) . Of the 108 cells (2 or 3 DIV) showing some activity in any of the treatment conditions, the number of cells exhibiting decreases or increases in spontaneous calcium transients fluctuated widely.
We next considered the possibility that long-term treatment of tectal neurons with glutamate receptor antagonists (the treatment that actually produced the increase in free neurite ends) might be necessary to discern an effect mediated by spontaneous calcium changes. We recorded the spontaneous calcium transients in cultures that were grown for 3 DIV in the various glutamate receptor antagonists. With this paradigm it was necessary to compare the average response of the population of cells grown under the different conditions. The tabulated results of these comparisons are given in Table 3 . None of the apparent changes in calcium transients after antagonist treatment suggested any correlation with the increased sprouting found in AP-5-and CNQX ϩ MCPG-treated cultures. For example, neither the average number of waves per cell nor the average number of spikes per cell was similarly altered from control values with CNQX ϩ MCPG and AP-5, as compared with the CNQX or MCPG alone, which does not induce sprouting. Thus, spontaneous calcium oscillations do not appear to be responsible for the sprout suppression mediated by glutamate receptor antagonists.
Some early Xenopus tectal neurons have a low sensitivity to magnesium ions
The existence of early NMDARs that function in the presence of magnesium would effectively account for the ability of NMDARs to suppress sprouting in the absence of AMPA/KAR function, particularly if mGluR function augmented the NMDAR re- Figure 3 , and the results of recording from several cells are summarized in Table 1. sponse. Our previous analysis at 3 DIV had revealed only NMDAR responses with normal magnesium sensitivity (Lin and Constantine-Paton, 1998) . However, we reasoned that the cells might change significantly during the 3 d in culture and that neurite sprouting might reflect an earlier responsiveness of NMDARs to endogenous glutamate that was no longer detectable at 3 DIV. Therefore, cultures were loaded with fluo-3 AM at 1 DIV, and changes in their calcium response to NMDA ϩ glycine were measured in the presence and absence of magnesium. Figure 6 A illustrates the responses of a typical field of cells when first exposed to NMDA ϩ glycine in 3 mM magnesium at 1 DIV, whereas Figure 6 B shows the responses of the same cells to multiple applications. Some neurons (Cell A) showed vigorous calcium responses to each pulse of NMDA in 3 mM magnesium, whereas other neurons (Cells C, E, F ) showed fluctuating responses under the same conditions. Other neurons (Cells B, D) never responded to NMDA in 3 mM magnesium. All of the cells responded in magnesium-free recording solution (Fig. 6 B, far  right) . Overall, 13 of 45 cells analyzed (29%) showed at least 20% of maximal NMDA response in magnesium-free solution when tested in 3 mM magnesium solution. This magnesium insensitivity was essentially gone when cells were similarly tested at 3 DIV. Only 1 of 49 cells (2%) examined at 3 DIV showed a significant NMDA current in 3 mM magnesium (data not shown). We next classified 1 DIV neurons using the procedure illustrated in Figure 6 as either normal type A (Cells B, D) or reduced magnesium sensitivity type B (Cells A, C, E, F ). We then examined the reduction of the calcium response in each type of neuron when antagonists of ionotropic and metabotropic glutamate receptors were present during glutamate application at 1 DIV (Fig.  7) . As expected, in the presence of CNQX, type A neurons showed a larger reduction in their calcium response to glutamate than did type B neurons. When MCPG was present along with CNQX, the response of the type A neurons was even more depressed. In contrast, the response of type B neurons in CNQX was unaffected by blocking type I/II mGluRs. Therefore it appears that only the magnesium-sensitive NMDARs are augmented by mGluR-mediated signaling.
These observations suggested that a combination of magnesium-insensitive NMDAR currents and small magnesiumsensitive NMDAR currents facilitated by mGluRs provide sufficient calcium flux to suppress sprouting in early contacted neurons. To examine this possibility we analyzed calcium responses to glutamate in the presence of specific mGluR antagonists and nifedipine at 1 DIV to compare the calcium response in the total population of neurons at 1 and 3 DIV. As shown by comparison between Figures 7B and 3 , the data differ in two respects between 1 and 3 DIV. First, CNQX is relatively less effective at blocking the calcium response to glutamate at the earlier age. Second, by 3 DIV (Fig. 3) the reduction in the calcium response is the same with either CNQX or nifedipine, whereas at 1 DIV (Fig. 7B ) nifedipine blocks significantly more calcium influx than CNQX. These differences imply that AMPA/KARs are not the only receptors driving L-type calcium channel activity in very young cultures, but that as the cultures mature, other Percentages reflect the glutamate current in the presence of antagonists relative to the glutamate current alone. CNQX decreases the cellular response to glutamate. Metabotropic glutamate antagonists that block type II mGluRs increase the glutamate current amplitude when applied individually, but when coapplied with CNQX they decrease the response of the cell to a larger extent than when CNQX is applied alone. The decay times for cells treated with CNQX and mGluR antagonist ϩ CNQX were calculated by first normalizing the amplitudes of the peak glutamate currents between the two treatments and then measuring the time from peak at 0.37 peak amplitude as a single exponential tau estimator. The decay time ratio is defined as the decay time in CNQX alone divided by the decay time in CNQX ϩ mGluR antagonist. Glu, Glutamate. sources of calcium channel activation disappear. This change may also explain why sprouting of contacted cells, as assayed after 3 d of treatment, is increased after exposure to nifedipine (Fig. 1 A,  Exp. 3) but not after exposure to CNQX (Fig. 1 A, Exp. 1) . The nifedipine block would eliminate all L-type calcium channel activity for the full duration of the treatment, whereas in very young cultures the CNQX block would only partially decrease calcium channel activity. In short, the three antagonist treatments that effectively eliminate sprout suppression among contacted cells at 3 DIV (AP-5, nifedipine, and CNQX ϩ EGLU) (Figs. 3, 7B , black bars) also consistently block the greatest proportion of the tectal neuron calcium response to glutamate at 1 DIV. Therefore, these treatments, when applied for the first 3 DIV, will produce greater decreases in glutamate-mediated calcium influx than the four antagonist treatments that have no effect on sprouting. A final observation was that blockade of type I/II mGluRs (Fig.  7A, MCPG) or selective blockade of type II mGluRs (Fig. 7B , EGLU ) increased the tectal neuron calcium response to glutamate, at least in neurons with normal NMDAR magnesium sensitivity (Fig. 7B ) (ANOVA Tukey post hoc test; p ϭ 0.0015). This was most pronounced at 1 DIV, but it was also seen in the calcium imaging data at 3 DIV (Fig. 3, EGLU, E4CPG) . Electrophysiological current measurements with either E4CPG or EGLU (Fig. 4 B; Table 1 ) also showed a similar increase. Three observations indicate that this is caused by type II mGluR suppression of AMPA/KAR-mediated calcium influx. First, AP-5 and CNQX block all glutamate-mediated calcium increases in these cells (Lin and Constantine-Paton, 1998) . Second, the effect on calcium influx is clearly reversed when AMPA/KARs are inactivated. Third, the presence of MCPG in addition to AP-5 results in a larger glutamate-induced calcium influx than AP-5 alone (Fig. 7A, Type A neurons) .
Type I/II mGluR antagonists and cAMP agonists decrease NMDAR response
Finally, we examined the transduction mechanism used by mGluRs to alter NMDAR f unction during glutamate stimulation. Acute EGLU exposure decreased the calcium response of both 1 and 3 DIV neurons to NMDA in magnesium-free solution but did not change the response of the cells in 3 mM magnesium (Fig. 8 A) . This suggests that the type II mGluR directly affects the calcium entry mediated by the NMDAR but does not change the receptor's sensitivity to magnesium ions.
Type II mGluRs are known to alter cytoplasmic levels of cAMP by regulating adenylate cyclase through trimeric G-proteins (Hollmann and Heinemann, 1994) . To examine the involvement of cAMP in the NMDAR-mediated calcium responses of tectal neurons, we used the cell-permeable cAMP analog 8-bromo-cAMP. Acute application of 5 or 10 M 8-Br-cAMP caused a significant reduction in NMDAR-mediated calcium influx in magnesium-free conditions at both 1 and 3 DIV (Fig. 8 B) . The effect was most pronounced at 1 DIV, although the effect of 5 M 8-Br-cAMP at 3 DIV was also significant. These data support a model in which type II mGluR activity depresses adenylate cyclase activity, and the resulting decrease in cAMP levels facilitates calcium influx through the NMDAR. When we experimentally block the type II mGluR, cAMP levels rise, and this increase mediates a reduction in calcium influx through theNMDAR. In combination with the blockade of AMPA/KARs, the reduced NMDAR calcium permeability is sufficient to reduce glutamate-mediated calcium influx to a level that no longer suppresses neurite sprouting. Time-lapse imaging of calcium transients in fields of cells were characterized at 2 and 3 DIV in normal FSS at intervals of 30 sec for 30 min. Glutamate receptor antagonists were then applied for 10 min, and a second set of time-lapse images of the spontaneous calcium transients of the same cells was collected as before. No consistent change in levels of spontaneous activity in individual cells was detected by comparing the calcium transients of antagonist-treated cells with the control images for those same cells. Sister cultures of tectal neurons were grown in normal media and supplemented with glutamate receptor antagonists as shown. Calcium transients were recorded for fields of cells every 30 sec for 30 min; the number and type of observed calcium changes were quantitated for each cell, and then the average response for all neurons in the field was calculated. Antagonists that produce an increased number of free neurite ends among contacted tectal neurons cannot be distinguished from treatments that do not increase free neurite ends in terms of their effects on calcium transients.
DISCUSSION
Our results demonstrate that all three classes of glutamate receptors can contribute to an early downregulation of sprouting that occurs during neuron -neuron contact before action potential activity mediates neurotransmission among cultured tectal cells (Lin and Constantine-Paton, 1998) . The decreased motility is most likely exerted by calcium influx. T ype II mGluR and AM PA / K AR antagonists in combination increase neurite sprouting from contacted cells, similar to that observed with NMDAR antagonists. Our calcium imaging data indicated that both treatments applied over the first 3 DIV would significantly reduce glutamate-mediated calcium influx. T ype II mGluR blockade decreases the glutamate-mediated calcium flux through NMDARs by ϳ20%, apparently working specifically on receptors with normal magnesium sensitivity. Recordings of glutamate-induced currents in the presence of various receptor antagonists are entirely consistent with the calcium imaging data. We also show that ϳ30% of very early Xenopus tectal neurons express NMDARs with a lowered magnesium sensitivity that would allow them to pass some calcium even in the absence of depolarization produced by AM PA / K ARs. In addition, we show that neither NMDAR antagonism nor AM PA / K AR and type II mGluR blockade alter spontaneous calcium transients in these tectal cells. Our evidence also suggests that the effect of type II mGluR blockade switches from decreasing to increasing glutamate-mediated calcium influx when AM PA / K AR currents are active.
Type II mGluR regulates ionotropic glutamate receptors through PKA
Type II mGluR regulation of adenylate cyclase activity has been linked to altered levels of cAMP in a number of systems (Prezeau et al., 1992; Flavin et al., 1996; Conn and Pin, 1997) , but the direction of the modulation appears to vary by location (Wang et al. , 1998; Beaver et al., 1999; Daw et al., 1999) . Our data are consistent with a normal role for type II mGluR activation in suppressing the activity of adenylate cyclase and decreasing cAMP levels. Although cAMP can act transcriptionally (for review, see De Cesare and Sassone-Corsi, 2000) or through the cAMP-dependent protein kinase (PKA) (for review, see Hatt, 1999) , the short latencies of responses induced by either type II mGluR antagonists or 8-bromo-cAMP suggest that the PKA pathway underlies the phenomena we have observed in tectal neurons. When type II mGluRs are blocked, increased cAMP levels might activate PKA and cause the changes that we observe in ionotropic glutamate receptor function. A PKA-dependent enhancement of AMPA/KAR function similar to that detected in tectal neurons has been documented to occur via direct phosphorylation at mature synapses (Wang et al., 1991; Banke et al., 2000; Snyder et al., 2000) . However, the mechanism through which PKA alters NMDAR permeability remains obscure. PKA has been shown to be a component of a protein complex associating with the NMDAR and the postsynaptic density protein yotiao (Westphal et al., 1999) . This could account for rapid PKA effects on NMDARs in mature neurons (Cerne et al., 1993; Nijholt et al., 2000) , but the differentiating neurons in our cultures probably do not have fully assembled postsynaptic scaffolding. Although glutamate release among contacted cells has been shown to mediate intracellular calcium increases even at these early stages (Lin and Constantine-Paton, 1998) , our recordings have not detected glutamate-mediated synaptic currents in tectal neurons before 5 DIV. Moreover, in more mature systems, PKA activity is associated with increased rather than decreased NMDAR activity (Westphal et al., 1999; Leveque et al., 2000) . Perhaps the younger cells that we have examined express an NMDAR subunit or subunit splice variant that allows PKAmediated phosphorylation to depress the activity of the receptor. It is also possible that PKA is not directly regulating the NMDAR in our system but rather functioning indirectly by regulating the activity of another kinase or phosphatase, as has been suggested by others (Nijholt et al., 2000) .
Numerous studies have noted an effect of mGluR activation on facilitating NMDAR f unction (Aniksztejn et al., 1991; Pisani et al., 1997; Holohean et al., 1999; Martin et al., 1999) , yet most of these effects are mediated by type I mGluRs. Metabotropic glutamate receptors have also been linked to the developmental appearance of NMDAR-only synapses in hippocampal micro-island cultures (Gomperts et al., 2000) . In Xenopus tectal neurons, type I mGluRs do not produce any effect on sprouting, and type I mGluR blockade has no effect on calcium influx when only NMDA ionotropic receptors are f unctioning. This difference may again result from the early stage of differentiation of these cells. glutamate-induced calcium response of tectal neurons. Nifedipine, however, depresses the calcium response to the same extent at both 1 (n ϭ 57 cells) and 3 DIV. The type II mGluR antagonist EGLU (but not the type I antagonist AIDA) in combination with CNQX further decreases the calcium entry in response to glutamate (n ϭ 48 cells). Neither mGluR antagonist alone reduces the calcium response to glutamate, and in fact the calcium response to glutamate when both ionotropic receptor types are functioning is actually increased in the presence of EGLU (ANOVA Tukey post hoc test; p ϭ 0.015). Black columns denote antagonists that resulted in increased free neurite ends among contacted cells after 3 d of chronic application in vitro. magnesium sensitivity in response to NMDA ϩ glycine stimulation. As expected, CNQX is less effective at decreasing the calcium influx in cells with low magnesium sensitivity compared with its effect on cells with normal magnesium sensitivity. The effect of type I/II mGluR and AMPA/KAR blockade (CNQXϩMCPG) on the calcium response to glutamate is also more pronounced in type A cells showing a normal magnesium sensitivity. MCPG alone actually increases the calcium response to glutamate in these type A neurons. MCPG ϩ AP-5 treatment yields a higher calcium influx through type A neurons compared with AP-5 alone, consistent with a normal weak suppression of calcium entry through AMPA/KAR receptors by type II mGluRs. B, Quantitation of the reduction of the calcium response to glutamate by glutamate receptor and calcium channel antagonists at 1 DIV. CNQX is relatively less effective at 1 DIV (n ϭ 57 cells) than at 3 DIV (Fig. 3) in blocking the
